To solve this, RISA Labs has raised a $3.5M funding round to help healthcare organizations eliminate one of the most persistent barriers to timely cancer care: prior authorization delays.

So says Kshitij Jaggi, co-founder and CEO of RISA Labs, a California-based start-up that is today announcing it has raised $3.5 million of seed round funding. The business’s goal is to reduce ...